Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon purchased 10,000 shares of the company’s stock in a transaction dated Wednesday, March 27th. The shares were acquired at an average price of $1.80 per share, for a total transaction of $18,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of CVRS traded down $0.03 during trading hours on Friday, reaching $2.05. 540,826 shares of the stock traded hands, compared to its average volume of 975,298. Corindus Vascular Robotics Inc has a 52-week low of $0.70 and a 52-week high of $2.54.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The company had revenue of $4.67 million during the quarter, compared to analysts’ expectations of $5.60 million.
COPYRIGHT VIOLATION NOTICE: “Louis A. Cannon Buys 10,000 Shares of Corindus Vascular Robotics Inc (CVRS) Stock” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/louis-a-cannon-buys-10000-shares-of-corindus-vascular-robotics-inc-cvrs-stock.html.
Corindus Vascular Robotics Company Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
See Also: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.